Author: Perucca E.
Publisher: Adis International
ISSN: 1172-7047
Source: CNS Drugs, Vol.10, Iss.3, 1998-09, pp. : 171-179
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
How should epilepsy in elderly patients be treated?
Inpharma, Vol. 1, Iss. 1235, 2000-01 ,pp. :
Treatment of Glioblastoma with Bevacizumab: Has a New Standard Therapy been Defined?
CNS Drugs, Vol. 25, Iss. 10, 2011-10 ,pp. :
How should patients with dyslipidaemia be monitored?
Inpharma, Vol. 1, Iss. 1652, 2008-01 ,pp. :
How should TNF inhibitors be used in rheumatoid arthritis?
Inpharma, Vol. 1, Iss. 1250, 2000-01 ,pp. :
How much should we be willing to pay?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 554, 2008-01 ,pp. :